These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24504326)

  • 81. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome.
    Boutry-Kryza N; Labalme A; Ville D; de Bellescize J; Touraine R; Prieur F; Dimassi S; Poulat AL; Till M; Rossi M; Bourel-Ponchel E; Delignières A; Le Moing AG; Rivier C; des Portes V; Edery P; Calender A; Sanlaville D; Lesca G
    Eur J Med Genet; 2015 Feb; 58(2):51-8. PubMed ID: 25497044
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Early-onset infant epileptic encephalopathy associated with a de novo
    Qian Y; Wu B; Lu Y; Dong X; Qin Q; Zhou W; Wang H
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455226
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders.
    Shepard N; Baez-Nieto D; Iqbal S; Kurganov E; Budnik N; Campbell AJ; Pan JQ; Sheng M; Farsi Z
    Sci Rep; 2024 Feb; 14(1):2798. PubMed ID: 38307912
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impaired vocal communication, sleep-related discharges, and transient alteration of slow-wave sleep in developing mice lacking the GluN2A subunit of N-methyl-d-aspartate receptors.
    Salmi M; Del Gallo F; Minlebaev M; Zakharov A; Pauly V; Perron P; Pons-Bennaceur A; Corby-Pellegrino S; Aniksztejn L; Lenck-Santini PP; Epsztein J; Khazipov R; Burnashev N; Bertini G; Szepetowski P
    Epilepsia; 2019 Jul; 60(7):1424-1437. PubMed ID: 31158310
    [TBL] [Abstract][Full Text] [Related]  

  • 85. NMDA receptor channel gating control by the pre-M1 helix.
    McDaniel MJ; Ogden KK; Kell SA; Burger PB; Liotta DC; Traynelis SF
    J Gen Physiol; 2020 Apr; 152(4):. PubMed ID: 32221541
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Imprecision in Precision Medicine: Differential Response of a Disease-Linked GluN2A Mutant to NMDA Channel Blockers.
    Gale JR; Kosobucki GJ; Hartnett-Scott KA; Aizenman E
    Front Pharmacol; 2021; 12():773455. PubMed ID: 34776984
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular basis of NMDA receptor functional diversity.
    Paoletti P
    Eur J Neurosci; 2011 Apr; 33(8):1351-65. PubMed ID: 21395862
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction.
    Siegler Retchless B; Gao W; Johnson JW
    Nat Neurosci; 2012 Jan; 15(3):406-13, S1-2. PubMed ID: 22246434
    [TBL] [Abstract][Full Text] [Related]  

  • 89. De novo KCNT1 mutations in early-onset epileptic encephalopathy.
    Ohba C; Kato M; Takahashi N; Osaka H; Shiihara T; Tohyama J; Nabatame S; Azuma J; Fujii Y; Hara M; Tsurusawa R; Inoue T; Ogata R; Watanabe Y; Togashi N; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
    Epilepsia; 2015 Sep; 56(9):e121-8. PubMed ID: 26140313
    [TBL] [Abstract][Full Text] [Related]  

  • 90. GRIN2A-related epilepsy and speech disorders: A comprehensive overview with a focus on the role of precision therapeutics.
    Samanta D
    Epilepsy Res; 2023 Jan; 189():107065. PubMed ID: 36516565
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mild neurological phenotype in a family carrying a novel N-terminal null GRIN2A variant.
    De Bernardi ML; Di Stazio A; Romano A; Minardi R; Bisulli F; Licchetta L; Aiello S; Carelli V; Brunetti-Pierri N; Cappuccio G; Terrone G
    Eur J Med Genet; 2022 May; 65(5):104500. PubMed ID: 35367634
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    Liu XR; Xu XX; Lin SM; Fan CY; Ye TT; Tang B; Shi YW; Su T; Li BM; Yi YH; Luo JH; Liao WP
    Front Mol Neurosci; 2021; 14():720984. PubMed ID: 34720871
    [No Abstract]   [Full Text] [Related]  

  • 93. Favorable Response to "Memantine" in a Child with GRIN2B Epileptic Encephalopathy.
    Chidambaram S; Manokaran RK
    Neuropediatrics; 2022 Aug; 53(4):287-290. PubMed ID: 34844267
    [No Abstract]   [Full Text] [Related]  

  • 94. Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-function.
    Myers SJ; Yuan H; Perszyk RE; Zhang J; Kim S; Nocilla KA; Allen JP; Bain JM; Lemke JR; Lal D; Benke TA; Traynelis SF
    Hum Mol Genet; 2023 Sep; 32(19):2857-2871. PubMed ID: 37369021
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.
    Prickett TD; Zerlanko BJ; Hill VK; Gartner JJ; Qutob N; Jiang J; Simaan M; Wunderlich J; Gutkind JS; Rosenberg SA; Samuels Y
    J Invest Dermatol; 2014 Sep; 134(9):2390-2398. PubMed ID: 24739903
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Perampanel therapy for intractable GRIN2D-related developmental and epileptic encephalopathy: A case report and literature review.
    Li J; Zhou Y; Su T; Xu S
    Brain Dev; 2023 Apr; 45(4):237-243. PubMed ID: 36567197
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A
    Zhang J; Tang W; Bhatia NK; Xu Y; Paudyal N; Liu D; Kim S; Song R; XiangWei W; Shaulsky G; Myers SJ; Dobyns W; Jayaraman V; Traynelis SF; Yuan H; Bozarth X
    Front Genet; 2021; 12():694312. PubMed ID: 34413877
    [No Abstract]   [Full Text] [Related]  

  • 98. Compound-heterozygous GRIN2A null variants associated with severe developmental and epileptic encephalopathy.
    Strehlow V; Rieubland C; Gallati S; Kim S; Myers SJ; Peterson V; Ramsey AJ; Teuscher DD; Traynelis SF; Lemke JR
    Epilepsia; 2022 Oct; 63(10):e132-e137. PubMed ID: 35983985
    [TBL] [Abstract][Full Text] [Related]  

  • 99. An Unusual Case of GRIN2A Mutation Presenting as Progressive Limbic Encephalopathy in an Adult.
    Heydarlou D; Asghari A; Ezzati S; Khalil M; Karim S; Lui F
    Cureus; 2024 Jun; 16(6):e63046. PubMed ID: 39050322
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
    D'mello SA; Flanagan JU; Green TN; Leung EY; Askarian-Amiri ME; Joseph WR; McCrystal MR; Isaacs RJ; Shaw JH; Furneaux CE; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
    Front Oncol; 2014 Jan; 3():333. PubMed ID: 24455489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.